RenovoRx, Inc.
NASDAQ:RNXTBiotechnology
-$0.01 today
- Market cap
- $54.04M
- Beta
- 0.99
- P/E (TTM)
- -3.4
- EPS (TTM)
- -$0.32
Volume 0.84M
Average 0.29M
RNXT Total Debt
Short-term and long-term borrowings combined.
RenovoRx, Inc.NASDAQ: RNXT
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt falls 34.3% from a year ago
Total debt stood at $186K at the end of Q1 FY2026, down 34.3% from a year earlier and down 12.3% from the prior quarter.
Context
- Total debt amounted to 1.3% of total assets at the end of Q1 FY2026, down 0.4 pp from a year earlier.
- Total debt increased in 1 of the last 3 fiscal years.
What to watch
Whether total debt keeps falling in the next quarterly balance sheet after a -34.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 212K USD
- Year-over-year change
- -23.7%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 212K | -23.7% |
| FY2024 | 2024-12-31 | 278K | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Total Debt vs competitors
How RNXT compares with its peers on the latest reported figures
- RNXT's Mar 2026 total debt of $186K is the 3rd highest of the 6 companies compared; the peer median is $59.08K.
- Its year-over-year change of -34.3% is the highest of 4, against a peer median of -69.7%.
- Total debt amounts to 1.3% of total assets for RNXT, versus a peer median of 0.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $40.9M | -40.6% | -14.6% | 38.1% | |
| Mar 2026 | $2.34M | -73.5% | -41.2% | 12.2% | |
| Mar 2026 | $186K | -34.3% | — | 1.3% | |
| Mar 2026 | $59.08K | -69.7% | +1040.9% | 0.8% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding RNXT) | $59.08K | -69.7% | -14.6% | 0.8% | |
Competitors are the stored peer set for RNXT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
RenovoRx, Inc.
NASDAQ:RNXT
Intrinsic Alpha fair value
Locked
Current Price
$1.12
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.